1. Psychopharmacologic Agents and Psychiatric Drug Considerations
- Author
-
Alan D. Kaye, Henry Liu, and Charles J. Fox
- Subjects
Drug ,medicine.medical_specialty ,business.industry ,media_common.quotation_subject ,Cognition ,Mental disease ,Mental illness ,medicine.disease ,Affect (psychology) ,Mental health ,Neuroleptic malignant syndrome ,medicine ,American population ,business ,Psychiatry ,media_common - Abstract
The clinical anesthesiologist should appreciate that mental illnesses, cognitive disorders, and mental health problems affect all walks of life. It is a fact that few families in America are untouched by mental illness. An estimated 26.2 % of Americans aged 18 and older suffer from a diagnosable mental disorder in a given year. Mental disease interferes with life activity and ability to function and constitutes a pervasive and prevalent health problem among varied American population subsets, including the young and the elderly. The presence of mental disorders, associated symptoms, possible concomitant pathology, and prescribed medications is of significance to all health-care providers and not simply those in the field of mental health.
- Published
- 2014
- Full Text
- View/download PDF